Header Logo

Connection

CHRISTIE BALLANTYNE to Obesity

Back to Details
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Obesity.
CHRISTIE BALLANTYNE
Connection Strength
3.891
Obesity
  1. Metabolic Inflammation and Insulin Resistance in Obesity. Circ Res. 2020 05 22; 126(11):1549-1564.
    View in: PubMed
    Score: 0.288
  2. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017 01 03; 127(1):43-54.
    View in: PubMed
    Score: 0.228
  3. Postprandial Monocyte Activation in Individuals With Metabolic Syndrome. J Clin Endocrinol Metab. 2016 11; 101(11):4195-4204.
    View in: PubMed
    Score: 0.222
  4. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance. Int J Obes (Lond). 2015 Nov; 39(11):1607-18.
    View in: PubMed
    Score: 0.204
  5. Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency. Atherosclerosis. 2014 Apr; 233(2):419-428.
    View in: PubMed
    Score: 0.186
  6. CD11c expression in adipose tissue and blood and its role in diet-induced obesity. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):186-92.
    View in: PubMed
    Score: 0.139
  7. Inflammation, adipose tissue, and T cells: what is the "straight skinny" on lean versus fat mice? Circ Res. 2009 Jul 17; 105(2):e3-4; author reply e5.
    View in: PubMed
    Score: 0.136
  8. Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J. 2009; 36(6):540-5.
    View in: PubMed
    Score: 0.131
  9. Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity. Obesity (Silver Spring). 2008 Dec; 16(12):2593-600.
    View in: PubMed
    Score: 0.129
  10. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends? Crit Pathw Cardiol. 2007 Jun; 6(2):41-5.
    View in: PubMed
    Score: 0.117
  11. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007 Feb 27; 115(8):1029-38.
    View in: PubMed
    Score: 0.115
  12. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006 Nov; 291(5):H2504-14.
    View in: PubMed
    Score: 0.109
  13. Eotaxin and obesity. J Clin Endocrinol Metab. 2006 Jan; 91(1):256-61.
    View in: PubMed
    Score: 0.105
  14. Natriuretic Peptide Cut Points for Heart Failure Classification in Individuals With and Without Obesity. Circ Heart Fail. 2025 Oct; 18(10):e013112.
    View in: PubMed
    Score: 0.104
  15. Adipokines and Transitions in Metabolic Health Over Time: The Atherosclerosis Risk In Communities (ARIC) Study. J Clin Endocrinol Metab. 2025 Aug 07; 110(9):e2939-e2945.
    View in: PubMed
    Score: 0.103
  16. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem. 2005 Jul; 51(7):1102-9.
    View in: PubMed
    Score: 0.103
  17. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab. 2004 Jun; 89(6):2697-703.
    View in: PubMed
    Score: 0.095
  18. The multifaceted life of macrophages in white adipose tissue: Immune shift couples with metabolic switch. Immunol Rev. 2024 07; 324(1):11-24.
    View in: PubMed
    Score: 0.095
  19. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab. 2002 Nov; 4(6):407-14.
    View in: PubMed
    Score: 0.085
  20. Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc. 2022 05 03; 11(9):e023238.
    View in: PubMed
    Score: 0.082
  21. Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed a High-Fat Diet. Diabetes. 2021 03; 70(3):720-732.
    View in: PubMed
    Score: 0.075
  22. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
    View in: PubMed
    Score: 0.065
  23. Weight History and Subclinical Myocardial Damage. Clin Chem. 2018 01; 64(1):201-209.
    View in: PubMed
    Score: 0.061
  24. Physical Activity, Obesity, and Subclinical?Myocardial Damage. JACC Heart Fail. 2017 05; 5(5):377-384.
    View in: PubMed
    Score: 0.058
  25. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63.
    View in: PubMed
    Score: 0.057
  26. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2016 Feb 16; 133(7):631-8.
    View in: PubMed
    Score: 0.053
  27. Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD. Circ Cardiovasc Genet. 2016 Feb; 9(1):71-8.
    View in: PubMed
    Score: 0.053
  28. A common variant in the CLDN7/ELP5 locus predicts adiponectin change with lifestyle intervention and improved fitness in obese individuals with diabetes. Physiol Genomics. 2015 Jun; 47(6):215-24.
    View in: PubMed
    Score: 0.050
  29. Obesity, subclinical myocardial injury, and incident heart failure. JACC Heart Fail. 2014 Dec; 2(6):600-7.
    View in: PubMed
    Score: 0.049
  30. The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals. J Obes. 2013; 2013:729515.
    View in: PubMed
    Score: 0.046
  31. Essential role of CD11a in CD8+ T-cell accumulation and activation in adipose tissue. Arterioscler Thromb Vasc Biol. 2014 Jan; 34(1):34-43.
    View in: PubMed
    Score: 0.046
  32. Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study. Circ Cardiovasc Genet. 2013 Aug; 6(4):391-9.
    View in: PubMed
    Score: 0.045
  33. Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study. Obesity (Silver Spring). 2013 May; 21(5):944-50.
    View in: PubMed
    Score: 0.044
  34. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study. Eur J Prev Cardiol. 2014 Jul; 21(7):866-75.
    View in: PubMed
    Score: 0.043
  35. Differential effect of weight loss with low-fat diet or high-fat diet restriction on inflammation in the liver and adipose tissue of mice with diet-induced obesity. Atherosclerosis. 2011 Nov; 219(1):100-8.
    View in: PubMed
    Score: 0.039
  36. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study. Arterioscler Thromb Vasc Biol. 2011 Jul; 31(7):1689-95.
    View in: PubMed
    Score: 0.038
  37. Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85.
    View in: PubMed
    Score: 0.038
  38. Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity. Obesity (Silver Spring). 2011 Mar; 19(3):505-13.
    View in: PubMed
    Score: 0.037
  39. Association of lactate with blood pressure before and after rapid weight loss. Am J Hypertens. 2008 Dec; 21(12):1337-42.
    View in: PubMed
    Score: 0.032
  40. Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities Study. Diabetes Obes Metab. 2007 Jul; 9(4):548-57.
    View in: PubMed
    Score: 0.029
  41. Global Effect of Cardiovascular Risk Factors on Lifetime Estimates. N Engl J Med. 2025 Jul 10; 393(2):125-138.
    View in: PubMed
    Score: 0.025
  42. Characteristics of US adults with the metabolic syndrome and therapeutic implications. Diabetes Obes Metab. 2004 Sep; 6(5):353-62.
    View in: PubMed
    Score: 0.024
  43. Six-year changes in N-terminal pro-brain natriuretic peptide and changes in weight and risk of obesity. Obesity (Silver Spring). 2021 07; 29(7):1215-1222.
    View in: PubMed
    Score: 0.019
  44. Development and assessment of antiatherosclerotic therapies beyond low-density lipoprotein cholesterol and blood pressure. Curr Atheroscler Rep. 2000 Jul; 2(4):281-3.
    View in: PubMed
    Score: 0.018
  45. Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. J Am Coll Cardiol. 2019 10 15; 74(15):1926-1942.
    View in: PubMed
    Score: 0.017
  46. Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD. Diabetes Care. 2015 Aug; 38(8):1544-50.
    View in: PubMed
    Score: 0.013
  47. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9.
    View in: PubMed
    Score: 0.012
  48. The association of plasma lactate with incident cardiovascular outcomes: the ARIC Study. Am J Epidemiol. 2013 Aug 01; 178(3):401-9.
    View in: PubMed
    Score: 0.011
  49. Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int J Epidemiol. 2010 Dec; 39(6):1647-55.
    View in: PubMed
    Score: 0.009
  50. Leptin and incident type 2 diabetes: risk or protection? Diabetologia. 2006 Sep; 49(9):2086-96.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.